Plain English
Targeted Osmotic Lysis, in everyday words
Targeted Osmotic Lysis, or TOL, is investigational. It is not approved by the FDA. It is not a treatment you can get here.
In everyday words
Some cancer cells can carry extra sodium channels. A channel is a tiny gate in the cell wall. Sodium is a salt the cell uses.
The published idea has three steps. First, open those gates. Second, block the pumps that bail sodium out. Third, water rushes in and the cell bursts. Researchers call that burst osmotic lysis.
That is the published hypothesis. It comes from lab and animal work. It is not a treatment this site offers, arranges, or refers anyone for.
In the published preclinical and veterinary research, the mechanism is described as not introducing cytotoxic chemotherapy agents, not using ionizing radiation, and not requiring surgical resection. That describes the studied mechanism only.
What has been studied
The homepage on FixCancer.org labels each published item by evidence type. Those labels are used here. They are research context. They are not a claim that TOL treats cancer in people.
- Narrative review, not original data
Reviews that summarize the proposed mechanism and earlier work on voltage-gated sodium channels in solid tumor cells. - Tertiary encyclopedia entry, not primary research
A secondary summary of the TOL concept, not a new experiment. - Preclinical laboratory and mouse study
Cell-culture and mouse work. Results in animals do not establish safety or effectiveness in people. - Preclinical cultured-cell study, meeting abstract
Early laboratory observations with limited peer review. No animals. No human subjects. - Animal safety study, no tumor endpoint
A safety study in healthy Beagle dogs. The authors report it as a safety evaluation, not a tumor study. - Companion-animal veterinary case series
An uncontrolled veterinary case series in companion animals with advanced carcinoma. - Single human case report
Human evidence is limited to individual case reports. Case reports cannot establish effectiveness. There are no published randomized trials.
The published research describes laboratory and veterinary study of stage 3 and stage 4 solid tumor carcinomas across several tissue types. Stage 3 and stage 4 are how doctors describe advanced cancer. This is research context. It is not an eligibility claim. It is not a signup form.
The published rationale focuses on solid tumor cells. Bone-based and blood-based cancers are described in the literature as outside that rationale.
Verifiable PubMed identifiers listed on the research home include 35453588, 36230549, 29643996, 32486340, 35967596, 34201380, and 39681070. Read them on PubMed. Do not treat a marketing page as the source.
Open the literature section on FixCancer.org.
What has not happened
- No FDA approval for any indication.
- No human trial of TOL registered on ClinicalTrials.gov. That includes Australia and every other country in that registry.
- Safety and effectiveness in humans are not established.
- This site does not offer, arrange, or refer anyone for treatment. It does not assess eligibility.
Common questions
Does this site offer or arrange cancer treatment?
No. It is educational. It does not offer, arrange, or refer anyone for treatment. It does not assess eligibility. It does not provide medical advice.
What is Targeted Osmotic Lysis (TOL)?
An investigational, research-stage mechanism studied in laboratory and veterinary models. The published hypothesis is that it disrupts cancer cell water balance. It is not FDA approved. Safety and effectiveness in humans are not established.
What human data exist?
The human evidence is limited to individual case reports. One is indexed in PubMed. Two others appear in a journal that is not indexed in PubMed or MEDLINE. Case reports cannot establish effectiveness. There are no published randomized trials and no human trials registered on ClinicalTrials.gov.
Does TOL use chemotherapy or radiation?
In the published preclinical and veterinary research, the mechanism is described as not introducing cytotoxic chemotherapy agents, not using ionizing radiation, and not requiring surgical resection. This describes the studied mechanism only.
Can I enroll if I have stage 3 or stage 4 cancer?
No. This site has no enrollment. Stage 3 and stage 4 language on these pages is research context from how doctors describe advanced cancer and from published laboratory and veterinary study. It is not an eligibility screen.
Is there an open trial in Australia?
No. There are no human trials of TOL registered on ClinicalTrials.gov. That includes Australia. You may ask a question about research in Australia as a topic. That question is not an application.
Ask a question
Ask a question by email. This is not enrollment. It is not a clinical intake. The form stores nothing. It opens your own email client addressed to contact@fixcancer.org. You send the message yourself.
Do not include medical records, diagnoses, lab results, or other protected health information. Questions about your own care belong with a licensed physician.